BC-CfE Anniversary Conversation Series | Chapter Two | The Early HAART Era: A Turning Point in HIV Care in BC

Cost: Free registration.

FEATURING:

Dr. Marianne Harris

Clinical Trials Physician
BC Centre for Excellence in HIV/AIDS

Dr. Silvia Guillemi
Clinical Consultant
Clinical Professor, Department
of Family Medicine, UBC


Tune in as BC-CfE Director of Clinical Education Dr. Val Montessori sits down with Drs. Silvia Guillemi and Marianne Harris to discuss how the advent of HAART in 1996 changed HIV care in BC.

Please register for the webinar by clicking the following link:

click here.

*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars

If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca.

DOWNLOAD POSTER PDF

Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below